Manufacturing News of Note—Halix boosts viral vector production; FDA reassures patients taking blood pressure meds


Here is some news of note for the week: 

> Halix, a CDMO in the Netherlands, says it completed a five-level production facility for making viral vaccines and viral vectors as well as protein manufacturing at its site in Leiden. Release

> The FDA issued a statement to try to ease consumer concerns over the risks of contaminated sartan drugs. Statement

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> The Novo Nordisk Foundation has awarded $27 million in grants to help the improve pharmaceutical processes to be easier on the environment. Release

> CDMO Sterling Pharma Solutions has started large-scale production of silica particles. Release

> Biocon says its insulin facility in Malaysia has been approved by the EU. Release

> Orano Med says it is investing €15 million in facilities in France and the U.S. to develop treatments using radioactive properties. Story

Suggested Articles

A suspected cancer-causing impurity that has been found in some blood pressure medicines has now shown up in Zantac and some OTC antacids.

Civica Rx, which last week hit its first anniversary, continues to strike deals that will help it to battle shortages and high costs for its healthcare members…

An Ipca Labs plant savaged in an FDA warning letter three years ago continues to fail manufacturing standards that would assure its drugs are safe.